MedPath
Found 1 clinical trials|View Analysis
Sort by:

FcRn Antagonists (Efgartigimod) for Acute NMOSD Attack

Phase 2
Not yet recruiting
Conditions
NMO Spectrum Disorder
Neuromyelitis Optica Spectrum Disorder
Neuromyelitis Optica
Interventions
First Posted Date
2024-07-11
Last Posted Date
2024-07-11
Lead Sponsor
Tianjin Medical University General Hospital
Target Recruit Count
63
Registration Number
NCT06497374
© Copyright 2025. All Rights Reserved by MedPath